Immunotherapy-Induced Overlap Syndrome: Myositis, Myasthenia Gravis, and Myocarditis—A Case Series
Immune checkpoint inhibitors (ICI) are monoclonal antibodies that target immune checkpoint inhibitory receptors. They have revolutionised cancer treatment but can be associated with a wide range of adverse side effects. Rarely, they can be associated with the triad of myositis, myasthenia gravis, an...
Saved in:
Main Authors: | Nikhil Aggarwal, Diletta Bianchini, Rosemeen Parkar, Jennifer Turner |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2024/5399073 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe Myositis, Myocarditis, and Myasthenia Gravis with Elevated Anti-Striated Muscle Antibody following Single Dose of Ipilimumab-Nivolumab Therapy in a Patient with Metastatic Melanoma
by: Mahdieh Fazel, et al.
Published: (2019-01-01) -
Severe Preeclampsia in the Setting of Myasthenia Gravis
by: Adam J. Lake, et al.
Published: (2017-01-01) -
Myasthenia Gravis Masquerading as Status Asthmaticus
by: Neha Pirwani, et al.
Published: (2021-01-01) -
Seronegative Myasthenia Gravis, as a Rare Autoimmune Condition in Turner Syndrome
by: Rimah Sharief, et al.
Published: (2017-01-01) -
New treatment options for generalized myasthenia gravis
by: Antanas Vaitkus, et al.
Published: (2024-02-01)